E-signing and witnessing of documents in COVID-19 times and beyond

This article discusses the current state of the law concerning electronic signature and witnessing of documents in Australia including so-called click-wrap contracts, e-signing laws and the specific electronic witnessing regulations arising from the COVID-19 pandemic.   In general, terms, Australian law establishes that most documents can be executed electronically.  There are exceptions for certain formal

COVID-19 – Trade Mark Office Practice Update

Australia The Australian Trade Marks Office’s operations have been largely unaffected by the coronavirus outbreak. Processing and examination timeframes have not been significantly impacted, and the day-to-day operations of the Office remain, for the most part, unchanged. The Australian Office has very recently implemented a process for granting free three months extensions of time in

Diagnostic Testing for SARS-CoV-2: How governments, regulators and the laboratory-diagnostics industry are responding to the challenge

In this article we examine how standard polymerase chain reaction (PCR) based testing for the novel coronavirus (SARS-CoV-2) works, explore the new CRISPR-based tests under development and the new rapid point-of-care tests being rolled out, and consider the initiatives by governments and medical device regulators to fast-track the availability of SARS-CoV-2 diagnostic tests.   Diagnostic

COVID-19: mRNA vaccines – a promising approach to vaccine development

The urgent need to develop an effective vaccine to provide individuals and populations worldwide with immunity against the COVID-19 disease caused by the novel coronavirus, SARS-CoV-2, has led several biotechnology companies to leverage messenger RNA (mRNA) technology and take a novel approach to vaccine development.   As the COVID-19 pandemic continues to unfold, there are